Zenflow
A minimally invasive implant system designed to relieve urinary symptoms caused by an enlarged prostate.
$52MSeries D
ParticipantC
ClavystBio
Activity from announced rounds
Activity in this selectionjens-urbaniak-f719b368
- Rounds participated in
- 3
- Confirmed lead rounds
- 0 2 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $122.4M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionLeyden Laboratories
Develops broadly protective antibody-based nasal sprays to prevent infection by influenza and other respiratory viruses
€40MSeries B
Role not disclosedRejoni
Develops a hydrogel system to treat uterine health conditions and prevent scarring
$25MSeries A
Role not disclosed